14 results on '"Casanova, Ciro"'
Search Results
2. Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease
- Author
-
Divo, Miguel J., Marin, José M., Casanova, Ciro, Cabrera Lopez, Carlos, Pinto-Plata, Victor M., Marin-Oto, Marta, Polverino, Francesca, de-Torres, Juan P., Billheimer, Dean, and Celli, Bartolome R.
- Published
- 2022
- Full Text
- View/download PDF
3. Plasma metabolomics and clinical predictors of survival differences in COPD patients
- Author
-
Pinto-Plata, Victor, Casanova, Ciro, Divo, Miguel, Tesfaigzi, Yohannes, Calhoun, Vince, Sui, Jing, Polverino, Francesca, Priolo, Carmen, Petersen, Hans, de Torres, Juan Pablo, Marin, Jose Maria, Owen, Caroline A., Baz, Rebeca, Cordova, Elizabeth, and Celli, Bartolome
- Published
- 2019
- Full Text
- View/download PDF
4. Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease
- Author
-
Guerra, Beniamino, Haile, Sarah R., Lamprecht, Bernd, Ramírez, Ana S., Martinez-Camblor, Pablo, Kaiser, Bernhard, Alfageme, Inmaculada, Almagro, Pere, Casanova, Ciro, Esteban-González, Cristóbal, Soler-Cataluña, Juan J., de-Torres, Juan P., Miravitlles, Marc, Celli, Bartolome R., Marin, Jose M., ter Riet, Gerben, Sobradillo, Patricia, Lange, Peter, Garcia-Aymerich, Judith, Antó, Josep M., Turner, Alice M., Han, Meilan K., Langhammer, Arnulf, Leivseth, Linda, Bakke, Per, Johannessen, Ane, Oga, Toru, Cosio, Borja, Ancochea-Bermúdez, Julio, Echazarreta, Andres, Roche, Nicolas, Burgel, Pierre-Régis, Sin, Don D., Soriano, Joan B., Puhan, Milo A., and for the 3CIA collaboration
- Published
- 2018
- Full Text
- View/download PDF
5. COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort.
- Author
-
Calle Rubio, Myriam, Rodriguez Hermosa, Juan Luis, de Torres, Juan P., Marín, José María, Martínez-González, Cristina, Fuster, Antonia, Cosío, Borja G., Peces-Barba, Germán, Solanes, Ingrid, Feu-Collado, Nuria, Lopez-Campos, Jose Luis, Casanova, Ciro, and CHAIN Study Investigators
- Subjects
OBSTRUCTIVE lung diseases ,QUALITY of life - Abstract
Background: Control in COPD is a dynamic concept that can reflect changes in patients' clinical status that may have prognostic implications, but there is no information about changes in control status and its long-term consequences.Methods: We classified 798 patients with COPD from the CHAIN cohort as controlled/uncontrolled at baseline and over 5 years. We describe the changes in control status in patients over long-term follow-up and analyze the factors that were associated with longitudinal control patterns and related survival using the Cox hazard analysis.Results: 134 patients (16.8%) were considered persistently controlled, 248 (31.1%) persistently uncontrolled and 416 (52.1%) changed control status during follow-up. The variables significantly associated with persistent control were not requiring triple therapy at baseline and having a better quality of life. Annual changes in outcomes (health status, psychological status, airflow limitation) did not differ in patients, regardless of clinical control status. All-cause mortality was lower in persistently controlled patients (5.5% versus 19.1%, p = 0.001). The hazard ratio for all-cause mortality was 2.274 (95% CI 1.394-3.708; p = 0.001). Regarding pharmacological treatment, triple inhaled therapy was the most common option in persistently uncontrolled patients (72.2%). Patients with persistent disease control more frequently used bronchodilators for monotherapy (53%) at recruitment, although by the end of the follow-up period, 20% had scaled up their treatment, with triple therapy being the most frequent therapeutic pattern.Conclusions: The evaluation of COPD control status provides relevant prognostic information on survival. There is important variability in clinical control status and only a small proportion of the patients had persistently good control. Changes in the treatment pattern may be relevant in the longitudinal pattern of COPD clinical control. Further studies in other populations should validate our results.Trial Registration: Clinical Trials.gov: identifier NCT01122758. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
6. Prospective comparison of non-invasive risk markers of major cardiovascular events in COPD patients.
- Author
-
Zagaceta, Jorge, Bastarrika, Gorka, Zulueta, Javier J., Colina, Inmaculada, Alcaide, Ana B., Campo, Arantza, Divo, Miguel, Casanova, Ciro, Marin, José M., Pinto-Plata, Victor M., Celli, Bartolome R., and de-Torres, Juan P.
- Subjects
OBSTRUCTIVE lung diseases ,CARDIOVASCULAR diseases ,PATIENTS ,CORONARY arteries ,HYPERTENSION ,PROGNOSIS ,DISEASE risk factors ,CARDIOVASCULAR disease diagnosis ,OBSTRUCTIVE lung disease diagnosis ,COMPARATIVE studies ,LONGITUDINAL method ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH ,SMOKING ,SPIROMETRY ,EVALUATION research ,CALCINOSIS ,DIAGNOSIS - Abstract
Background: Chronic Obstructive Pulmonary Disease (COPD) is an independent risk factor for cardiovascular (CV) disease, one of the most frequent causes of death in COPD patients. The goal of the present study was to evaluate the prognostic value of non-invasive CV risk markers in COPD patients.Methods: CV risk was prospectively evaluated in 287 COPD patients using non-invasive markers including the Framingham score, the Systematic Coronary Risk Evaluation (SCORE) charts, coronary arterial calcium (CAC), epicardial adipose tissue (EAT), as well as clinical, biochemical and physiological variables. The predictive power of each parameter was explored using CV events as the main outcome.Results: During a median follow up of 65 months (ICR: 36-100), 44 CV events were recorded, 12 acute myocardial infarctions (27.3%), 10 ischemic heart disease/angina (22.7%), 12 peripheral artery disease events requiring surgery (27.3%) and 10 strokes (22.7%). A total of 35 CV deaths occurred during that period. Univariable analysis determined that age, hypertension, CRP, total Cholesterol, LDL-Cholesterol, Framingham score and CAC were independently associated with CV events. Multivariable analysis identified CAC as the best predictor of CV events (HR; 95%CI: 1.32; 1.19-1.46, p < 001).Conclusions: In COPD patients attending pulmonary clinics, CAC was the best independent non-invasive predictor of CV events. This tool may help evaluate the risk for a CV event in patients with COPD. Larger studies should reproduce and validate these findings. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
7. Telomere shortening and accelerated aging in COPD: findings from the BODE cohort.
- Author
-
Elizabeth, Córdoba-Lanús, Sara, Cazorla-Rivero, Adriana, Espinoza-Jiménez, de-Torres, Juan P., María-José, Pajares, Armando, Aguirre-Jaime, Bartolomé, Celli, Ciro, Casanova, Córdoba-Lanús, Elizabeth, Cazorla-Rivero, Sara, Espinoza-Jiménez, Adriana, Pajares, María J, Aguirre-Jaime, Armando, Celli, Bartolomé, and Casanova, Ciro
- Subjects
OBSTRUCTIVE lung disease diagnosis ,OBSTRUCTIVE lung diseases patients ,TELOMERES ,CIGARETTE smokers ,AGING - Abstract
Background: Chronic Obstructive Pulmonary Disease (COPD) may be associated with accelerated aging. Telomere shortening is a biomarker of aging. Cross-sectional studies describe shorter telomeres in COPD compared with matched controls. No studies have described telomere length trajectory and its relationship with COPD progression. We investigated telomere shortening over time and its relationship to clinical and lung function parameters in a COPD cohort and smoker controls without COPD.Methods: At baseline leukocyte telomere length was measured by qPCR in 121 smokers with COPD and 121 without COPD matched by age (T/S0). The measurements were repeated in 70 of those patients with COPD and 73 non-COPD smokers after 3 years of follow up (T/S3).Results: At initial measurement, telomeres were shorter in COPD patients when compared to smoker controls (T/S = 0.68 ± 0.25 vs. 0.88 ± 0.52, p = 0.003) independent from age and sex. During the follow-up period, we observed an accelerated telomere shortening in individuals with COPD in contrast to smoker controls (T/S0 = 0.66 ± 0.21 vs. T/S3 = 0.46 ± 0.16, p < 0.001, for the patients with COPD and T/S0 = 0.83 ± 0.56 vs. T/S3 = 0.74 ± 0.52, p = 0.023 for controls; GLIM, p = 0.001). This shortening was inversely related to the baseline telomere length (r = -0.49, p < 0.001). No significant relationship was found between the rate of change in telomere length and change in lung function in the patients with COPD (p > 0.05).Conclusions: Compared with smokers, patients with COPD have accelerated telomere shortening and this rate of attrition depends on baseline telomere length. Furthermore, the telomere length and its rate of shortening did not relate to clinical and lung function parameters changes over 3 years of follow-up. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
8. New GOLD classification: longitudinal data on group assignment.
- Author
-
Casanova, Ciro, Marin, Jose M., Martinez-Gonzalez, Cristina, de Lucas-Ramos, Pilar, Mir-Viladrich, Isabel, Cosio, Borja, Peces-Barba, German, Calle-Rubio, Miryam, Solanes-García, Ingrid, Agüero, Ramón, de Diego-Damia, Alfredo, Feu-Collado, Nuria, Alfageme, Inmaculada, Irigaray, Rosa, Balcells, Eva, Llunell, Antonia, Galdiz, Juan Bautista, Marín, Margarita, Soler-Cataluña, Juan José, and Lopez-Campos, Jose Luis
- Subjects
- *
OBSTRUCTIVE lung diseases , *SPIROMETRY , *DISEASE progression , *LONGITUDINAL method , *DYSPNEA - Abstract
Rationale: Little is known about the longitudinal changes associated with using the 2013 update of the multidimensional GOLD strategy for chronic obstructive pulmonary disease (COPD). Objective: To determine the COPD patient distribution of the new GOLD proposal and evaluate how this classification changes over one year compared with the previous GOLD staging based on spirometry only. Methods: We analyzed data from the CHAIN study, a multicenter observational Spanish cohort of COPD patients who are monitored annually. Categories were defined according to the proposed GOLD: FEV1%, mMRC dyspnea, COPD Assessment Test (CAT), Clinical COPD Questionnaire (CCQ), and exacerbations-hospitalizations. One-year follow-up information was available for all variables except CCQ data. Results: At baseline, 828 stable COPD patients were evaluated. On the basis of mMRC dyspnea versus CAT, the patients were distributed as follows: 38.2% vs. 27.2% in group A, 17.6% vs. 28.3% in group B, 15.8% vs. 12.9% in group C, and 28.4% vs. 31.6% in group D. Information was available for 526 patients at one year: 64.2% of patients remained in the same group but groups C and D show different degrees of variability. The annual progression by group was mainly associated with one-year changes in CAT scores (RR, 1.138; 95%CI: 1.074-1.206) and BODE index values (RR, 2.012; 95%CI: 1.487-2.722). Conclusions: In the new GOLD grading classification, the type of tool used to determine the level of symptoms can substantially alter the group assignment. A change in category after one year was associated with longitudinal changes in the CAT and BODE index. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
9. Inflammatory and repair serum biomarker pattern. Association to clinical outcomes in COPD.
- Author
-
Pinto-Plata, Victor, Casanova, Ciro, Müllerova, Hana, de Torres, Juan P., Corado, Henneth, Varo, Nerea, Cordoba, Elizabeth, Zeineldine, Salah, Paz, Hildegarde, Baz, Rebeca, Divo, Miguel, Cortopassi, Felipe, and Celli, Bartolome R.
- Subjects
- *
SEROTHERAPY , *BIOMARKERS , *OBSTRUCTIVE lung disease treatment , *INFLAMMATION , *VASCULAR endothelial growth factors , *MATRIX metalloproteinases , *QUALITY of life - Abstract
Background: The relationship between serum biomarkers and clinical expressions of COPD is limited. We planned to further describe this association using markers of inflammation and injury and repair. Methods: We studied lung function, comorbidities, exercise tolerance, BODE index, and quality of life in 253 COPD patients and recorded mortality over three years. Serum levels of Interleukins 6,8 and16, tumor necrosis factor alpha (TNF α) [inflammatory panel], vascular endothelial growth factor (VEGF), and matrix metalloproteinase 9 (MMP-9) [injury and repair panel] and pulmonary and activation-regulated chemokine (PARC/CCL-18) and monocyte chemotactic protein 1 (MCP-1/CCL2) [chemoattractant panel] were measured. We related the pattern of the biomarker levels to minimal clinically important differences (MCID) using a novel visualization method [ObServed Clinical Association Results (OSCAR) plot]. Results: Levels of the inflammatory markers IL-6, TNF α were higher and those of injury and repair lower (p < 0.01) with more advanced disease (GOLD 1 vs. 4). Using the OSCAR plot, we found that patients in the highest quartile of inflammatory and lowest quartile of injury and repair biomarkers level were more clinically compromised and had higher mortality (p < 0.05). Conclusions: In COPD, serum biomarkers of inflammation and repair are distinctly associated with important clinical parameters and survival. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
10. Gender and respiratory factors associated with dyspnea in chronic obstructive pulmonary disease.
- Author
-
De Torres, Juan P., Casanova, Ciro, Montejo de Garcini, Angela, Aguirre-Jaime, Armando, and Celli, Bartolome R.
- Subjects
- *
DYSPNEA , *OBSTRUCTIVE lung diseases , *GENDER role , *MULTIVARIATE analysis ,SEX differences (Biology) - Abstract
Objectives: Evaluate gender differences in respiratory factors associated with dyspnea in COPD patients. Methods: In a FEV1 % matched population of 100 men and women with COPD we measured: age, MMRC, FEV1, FVC, TLC, IC/TLC, PaO2, PaCO2, DLCO, Pimax, P0.1, Ti/Ttot, BMI, ffmi, 6MWD and VAS scale before and after the test, the Charlson score and the SGRQ. We estimated the association between these parameters and MMRC scores. Multivariate analysis determined the independent strength of those associations. Results: MMRC correlated with: BMI (men:-0.29, p = 0.04; women:-0.28, p = 0.05), ffmi (men:- 0.39, p = 0.01), FEV1 % (men:-0.64, p < 0.001; women:-0.29, p = 0.04), FVC % (men:-0.45, p = 0.001; women:-0.33, p = 0.02), IC/TLC (men:-0.52, p < 0.001; women: -0.27, p = 0.05), PaO2 (men:-0.59, p < 0.001), PaCO2 (men:0.27, p = 0.05), DLCO (men:-0.54, p < 0.001), P0.1/Pimax (men:0.46, p = 0.002; women:0.47, p = 0.005), dyspnea measured with the Visual Analog Scale before (men:0.37, p = 0.04; women:0.52, p = 0.004) and after 6MWD (men:0.52, p = 0.002; women:0.48, p = 0.004) and SGRQ total (men:0.50, p < 0.001; women:0.59, p < 0.001). Regression analysis showed that P0.1/Pimax in women (r2 = 0.30) and BMI, DLCO, PaO2 and P0.1/Pimax in men (r2 = 0.81) were the strongest predictors of MMRC scores. Conclusion: In mild to severe COPD patients attending a pulmonary clinic, P0.1/Pimax was the unique predictor of MMRC scores only in women. Respiratory factors explain most of the variations of MMRC scores in men but not in women. Factors other than the respiratory ones should be included in the evaluation of dyspnea in women with COPD. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
11. Gender associated differences in determinants of quality of life in patients with COPD: a case series study.
- Author
-
de Torres, Juan P., Casanova, Ciro, Hernández, Concepción, Abreu, Juan, de Garcini, Angela Montejo, Aguirre-Jaime, Armando, and Celli, Bartolome R.
- Subjects
- *
OBSTRUCTIVE lung diseases , *QUALITY of life , *HEALTH outcome assessment , *HEALTH status indicators ,SEX differences (Biology) - Abstract
Background: The influence of gender on the expression of COPD has received limited attention. Quality of Life (QoL) has become an important outcome in COPD patients. The aim of our study was to explore factors contributing to gender differences in Quality of Life of COPD patients. Methods: In 146 men and women with COPD from a pulmonary clinic we measured: Saint George's Respiratory Questionnaire (SGRQ), age, smoking history, PaO2, PaCO2, FEV1, FVC, IC/TLC, FRC, body mass index (BMI), 6 minute walk distance (6MWD), dyspnea (modified MRC), degree of comorbidity (Charlson index) and exacerbations in the previous year. We explored differences between genders using Mann-Whitney U-rank test. To investigate the main determinants of QoL, a multiple lineal regression analysis was performed using backward Wald's criteria, with those variables that significantly correlated with SGRQ total scores. Results: Compared with men, women had worse scores in all domains of the SGRQ (total 38 vs 26, p = 0.01, symptoms 48 vs 39, p = 0.03, activity 53 vs 37, p = 0.02, impact 28 vs 15, p = 0.01). SGRQ total scores correlated in men with: FEV1% (-0.378, p < 0.001), IC/TLC (-0.368, p = 0.002), PaO2 (-0.379, p = 0.001), PaCO2 (0.256, p = 0.05), 6MWD (-0.327, p = 0.005), exacerbations (0.366, p = 0.001), Charlson index (0.380, p = 0.001) and MMRC (0.654, p < 0.001). In women, the scores correlated only with FEV1% (-0.293, p = 0.013) PaO2 (-0.315, p = 0.007), exacerbations (0.290, p = 0.013) and MMRC (0.628, p < 0.001). Regression analysis (B, 95% CI) showed that exercise capacity (0.05, 0.02 to 0.09), dyspnea (17.6, 13.4 to 21.8), IC/TLC (-51.1, -98.9 to -3.2) and comorbidity (1.7, 0.84 to 2.53) for men and dyspnea (9.7, 7.3 to 12.4) and oxygenation (-0.3, -0.6 to -0.01) for women manifested the highest independent associations with SGRQ scores. Conclusion: In moderate to severe COPD patients attending a pulmonary clinic, there are gender differences in health status scores. In turn, the clinical and physiological variables independently associated with those scores differed in men and women. Attention should be paid to the determinants of QoL scores in women with COPD. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
12. Inflammatory and Repair Serum Biomarker Pattern. Association to Clinical Outcomes in COPD
- Author
-
Casanova, Ciro, Müllerova, Hana, de Torres, Juan P, Corado, Henneth, Varo, Nerea, Cordoba, Elizabeth, Zeineldine, Salah, Paz, Hildegarde, Baz, Rebeca, Cortopassi, Felipe, Pinto-Plata, Victor Manuel, Divo, Miguel Jose, and Celli, Bartolome R
- Subjects
Exercise ,Inflammation ,Phenotypes ,Repair ,Survival - Abstract
Background: The relationship between serum biomarkers and clinical expressions of COPD is limited. We planned to further describe this association using markers of inflammation and injury and repair. Methods: We studied lung function, comorbidities, exercise tolerance, BODE index, and quality of life in 253 COPD patients and recorded mortality over three years. Serum levels of Interleukins 6,8 and16, tumor necrosis factor alpha (TNF α) [inflammatory panel], vascular endothelial growth factor (VEGF), and matrix metalloproteinase 9 (MMP-9) [injury and repair panel] and pulmonary and activation-regulated chemokine (PARC/CCL-18) and monocyte chemotactic protein 1 (MCP-1/CCL2) [chemoattractant panel] were measured. We related the pattern of the biomarker levels to minimal clinically important differences (MCID) using a novel visualization method [ObServed Clinical Association Results (OSCAR) plot]. Results: Levels of the inflammatory markers IL-6, TNF α were higher and those of injury and repair lower (p < 0.01) with more advanced disease (GOLD 1 vs. 4). Using the OSCAR plot, we found that patients in the highest quartile of inflammatory and lowest quartile of injury and repair biomarkers level were more clinically compromised and had higher mortality (p < 0.05). Conclusions: In COPD, serum biomarkers of inflammation and repair are distinctly associated with important clinical parameters and survival.
- Published
- 2012
- Full Text
- View/download PDF
13. Erratum to: Telomere shortening and accelerated aging in COPD: findings from the BODE cohort.
- Author
-
Cordoba-Lanus, Elizabeth, Cazorla-Rivero, Sara, Espinoza-Jimenez, Adriana, de-Torres, Juan P, Pajares, María J, Aguirre-Jaime, Armando, Celli, Bartolomé, and Casanova, Ciro
- Subjects
TELOMERES ,OBSTRUCTIVE lung diseases ,AGING - Abstract
A correction to the article "Telomere shortening and accelerated aging in COPD: findings from the BODE cohort" in the previous issue is presented.
- Published
- 2017
- Full Text
- View/download PDF
14. TNFA-863 polymorphism is associated with a reduced risk of chronic obstructive pulmonary disease: a replication study.
- Author
-
Córdoba-Lanús E, Baz-Dávila R, de-Torres JP, Rodríguez-Pérez MC, Maca-Meyer N, Varo N, Medina-Coello C, Aguirre-Jaime A, and Casanova C
- Subjects
- Aged, Cohort Studies, Female, Haplotypes, Humans, Male, Middle Aged, Pulmonary Disease, Chronic Obstructive epidemiology, Risk Factors, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Pulmonary Disease, Chronic Obstructive genetics, Tumor Necrosis Factor-alpha genetics
- Abstract
Unlabelled: :, Background: TNF-α mediated inflammation is thought to play a key role in the respiratory and systemic features of Chronic Obstructive Pulmonary Disease. The aim of the present study was to replicate and extend recent findings in Taiwanese and Caucasian populations of associations between COPD susceptibility and variants of the TNFA gene in a Spanish cohort., Methods: The 3 reported SNPs were complemented with nine tag single nucleotide polymorphisms (SNP) of the TNFA and LTA genes and genotyped in 724 individuals (202 COPD patients, 90 smokers without COPD and 432 healthy controls). Pulmonary function parameters and serum inflammatory markers were also measured in COPD patients., Results: The TNFA rs1800630 (-863C/A) SNP was associated with a lower COPD susceptibility (ORadj = 0.50, 95% CI = 0.33-0.77, p = 0.001). The -863A allele was also associated with less severe forms of the disease (GOLD stages I and II) (ORadj = 0.303, 95%CI = 0.14-0.65, p = 0.014) and with lower scores of the BODE index (< 2) (ORadj = 0.40, 95%CI = 0.17-0.94, p = 0.037). Moreover, the -863A carrier genotype was associated with a better FEV1 percent predicted (p = 0.004) and a lower BODE index (p = 0.003) over a 2 yrs follow-up period. None of the TNFA or LTA gene variants correlated with the serum inflammatory markers in COPD patients (p > 0.05)., Conclusions: We replicated the previously reported association between the TNFA -863 SNP and COPD. TNFA -863A allele may confer a protective effect to the susceptibility to the disease in the Spanish population.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.